Memorial Park Conservancy's renovations include some projects that are rare or never been done before. Photo courtesy of MPC

Memorial Park is undergoing a huge transformation that is mixing a little bit of old with the new.

The Memorial Park Master Plan includes adding breathtaking new projects — like water features, a new athletic complex, and more — as well as conservation efforts that restore parts of the land that were native coastal prairie. The project is a collaborative effort between Memorial Park Conservancy, Uptown Houston TIRZ, and Houston Parks and Recreation Department to redevelop the 1,500-acre park.

The Master Plan is set to deliver a series of projects ahead of 2028, and there are a few initiatives that are innovative and different from other urban parks' transformations, notes MPC's president and CEO Shellye Arnold.

The Land Bridge

Photo courtesy of MPC

A big part of Memorial Park's transformation is restoring the park to native species and ecosystems.

"We're taking ball fields, parking lots, and roads and converting them back to what was here — native wetland coastal prairie," Arnold says. "This serves important stormwater purposes."

In order to connect two native coastal prairie lands on either side of Memorial Drive, MPC is building a unique 30-foot-high land bridge the size of three-and-a-half football fields. The space will be large enough that you don't even realize you're standing over a busy street, Arnold says.

The prairies will serve an important purpose for rainwater collection — a growing need within the city of Houston.

"We're channeling [rainwater] into this prairie where some of it can be absorbed, cleansed, slowed down," says Arnold. "And then what doesn't get slowed down and absorbed can flow through the prairie [on the other side], which is even bigger."

The Land Bridge also serves another purpose that park goers have wanted, Arnold says: Connectivity.

"[They] want access across the Memorial Drive — [they] want to safe access, and so this is the response. It's a pretty bold and visionary response," Arnold says.

BioCycling

Photo courtesy of MPC

In 2011, a major drought decimated the park and areas saw losses of 50 to even 90 percent of the canopy of trees. MPC and its team saved what could be saved, and the rest is serving a new purpose to the park.

"We took the trees that we lost on the drought that people felt such a tremendous loss for and ground them all up, and they are in a biocycle in a two-acre area in the back of the park," Arnold says.

The soil created — some of which includes manure from the animals at the Houston Zoo — has already been used on some plants in the park, and Arnold says those plants are thriving.

"It's cool that those those trees are giving life to the park," Arnold says.

Invasive species of trees that are plucked from out of the park are also being ground up and used in the same way.

"There isn't anything this big like this in an urban park setting like this kind of recycling effort," she says.

The biocycling process is scalable too.

"We could open this up to other organizations," Arnold says. "It's so much better ecologically to take trees and grind them up and use it inside the space rather than haul them out to landfill way outside of town and dump them."

The benefit to the program is that MPC can retain some of the soil it produces for these other organizations and use it on site.

Biodiversity initiatives and research

Photo courtesy of MPC

When putting the plans in place, MPC and its partners called on 25 of the best ecologists, as well as 50 more park and other types of consultants specializing in everything from insects and wildlife to prairies and trees.

Just as the Land Bridge is creating new prairie space, other initiatives throughout the park will be focused on eliminating invasive species and bringing back the natural ecosystem of the park.

The Easter Glades project, which is set to deliver next year, will have a habitat for fish, and will not allow any fishing or boating. Carolyn White, conservation director at MPC, is working with the Texas Wildlife Association to bring in the right species of fish.

Arnold says that MPC works with other organizations in an innovative way to bring native plants into MPC, since the park has the space for these organizations to use to cultivate and propagate plants.

"They bring their native plants and they grow them with their volunteers, and they leave us a little bit here," Arnold says. "We could never buy enough native plants to go inside this park."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

CPRIT CEO: Houston’s $2B in funding is transforming cancer research and prevention

fighting cancer

With its plethora of prestigious health care organizations like the University of Texas MD Anderson Cancer Center, UTHealth Houston, and the Baylor College of Medicine, Houston sits at the heart of cancer research and prevention in Texas.

Of course, it takes piles of cash to support Houston’s status as the state’s hub for cancer research and prevention. Much of that money comes from the Cancer Prevention and Research Institute of Texas (CPRIT).

Data supplied by CPRIT shows organizations in Harris County gained $2.3 billion in institute funding from 2009 through 2025, or nearly $145 million per year. That represents almost 60 percent of the roughly $4 billion that CPRIT has granted to Texas institutions over a 16-year period.

“The life sciences ecosystem that has developed and changed in Houston is phenomenal,” Kristen Doyle, who became the agency’s CEO in July 2024, tells InnovationMap. “In the next decade, we will look back and see a great transformation.”

That ecosystem includes more than 1,100 life sciences and biotech companies, according to the Greater Houston Partnership.

Houston plays critical role in clinical trials

Texas voters approved the creation of CPRIT in 2007. Twelve years later, voters agreed to earmark an extra $3 billion for CPRIT, bringing the state agency’s total investment in cancer research and prevention to $6 billion.

To date, CPRIT money has gone toward recruiting 344 cancer researchers to Texas (mainly to Houston) and has supported cancer prevention services for millions of Texans in the state’s 254 counties. CPRIT funding has also helped establish, expand, or relocate 25 cancer-focused companies. In Houston, MD Anderson ranks as the No. 1 recipient of CPRIT funding.

Regarding cancer research, Doyle says Houston plays a critical role in clinical trials.

“[Clinical trials are] something that CPRIT has focused on more and more. Brilliant discoveries are crucial to this whole equation of solving the cancer problem,” Doyle says. “But if those brilliant ideas stay in the labs, then we’ve all failed.”

Researchers conduct more clinical trials in Houston than anywhere else in the U.S., the Greater Houston Partnership says.

Doyle, a 20-year survivor of leukemia, notes that a minority of eligible patients participate in clinical trials for cancer treatments, “and that’s one of the reasons that it takes so long to get a promising drug to market.”

An estimated 7 percent of cancer patients sign up for clinical trials, according to a study published in 2024 in the Journal of Clinical Oncology.

MD Anderson takes on cancer prevention

Doyle also notes that Houston is leading the charge in cancer prevention.

“We get some national recognition for programs that have been developed in Houston that then can be replicated in other parts of the country,” she says.

Much of the work in Houston focusing on cancer prevention takes place at MD Anderson. The hospital reports that it has received more than $725 million from the CPRIT since 2007, representing approximately 18 percent of CPRIT’s total awards.

“These efforts can have profound impact on the lives of patients and their families, and this funding ensures our exemplary clinicians and scientists can continue working together to drive breakthroughs that advance our mission to end cancer,” Dr. Giulio Draetta, chief scientific officer at MD Anderson, said in a November news release, following the most recent CPRIT award for the hospital totalling more than $29 million.

CPRIT funding for Houston institutions supplements the more than $4.5 billion in federal funding for health and life sciences research and innovations that the Houston area received from 2020 to 2024, according to the Greater Houston Partnership.

“We are curing cancer every single day,” Doyle says of CPRIT. “Every step that we are taking — whether that’s funding great ideas or funding the clinical trials that are bringing promising drugs to Texas and to the world — we are making a difference.”

Houston energy tech co. breaks ground on low-cost hydrogen pilot plant

Coming Soon

Houston’s Lummus Technology and Advanced Ionics have broken ground on their hydrogen pilot plant at Lummus’ R&D facility in Pasadena, Texas.

The plant will support Advanced Ionics’ cutting-edge electrolyzer technology, which aims to deliver high-efficiency hydrogen production with reduced energy requirements.

“By demonstrating Advanced Ionics’ technology at our state-of-the-art R&D facility, we are leveraging the expertise of our scientists and R&D team, plus our proven track record of developing breakthrough technologies,” Leon de Bruyn, president and CEO of Lummus, said in a news release. “This will help us accelerate commercialization of the technology and deliver scalable, cost-effective and sustainable green hydrogen solutions to our customers.”

Advanced Ionics is a Milwaukee-based low-cost green hydrogen technology provider. Its electrolyzer converts process and waste heat into green hydrogen for less than a dollar per kilogram, according to the company. The platform's users include industrial hydrogen producers looking to optimize sustainability at an affordable cost.

Lummus, a global energy technology company, will operate the Advanced Ionics electrolyzer and manage the balance of plant systems.

In 2024, Lummus and Advanced Ionics established their partnership to help advance the production of cost-effective and sustainable hydrogen technology. Lummus Venture Capital also invested an undisclosed amount into Advanced Ionics at the time.

“Our collaboration with Lummus demonstrates the power of partnerships in driving the energy transition forward,” Ignacio Bincaz, CEO of Advanced Ionics, added in the news release. “Lummus serves as a launchpad for technologies like ours, enabling us to validate performance and integration under real-world conditions. This milestone proves that green hydrogen can be practical and economically viable, and it marks another key step toward commercial deployment.”

---

This article originally appeared on EnergyCapitalHTX.com.

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.